The Medtronic MiniMed 670G, which the FDA recently approved for type 1 diabetics ages 14 and older. It’s due to go on the market in the spring; it monitors glucose levels and administers insulin automatically.
The Medtronic MiniMed 670G, which the FDA recently approved for type 1 diabetics ages 14 and older. It’s due to go on the market in the spring; it monitors glucose levels and administers insulin automatically.
The Medtronic MiniMed 670G, which the FDA recently approved for type 1 diabetics ages 14 and older. It’s due to go on the market in the spring; it monitors glucose levels and administers insulin automatically.

Just like the pancreas, new device monitors glucose and delivers insulin automatically

November 22, 2016 10:44 PM

UPDATED November 23, 2016 11:50 AM

More Videos

  • It's only temporary - smartphone blindness

    Smartphone habits may force doctors to ask patients a few more questions when diagnosing vision or neurological problems. “I think if a person experiences a temporary loss of vision in one eye, that’s potentially a very important problem for which they should seek medical attention,” says Mayo Clinic neurologist Dr. Dean Wingerchuk. “But, it doesn’t always mean there’s an abnormality.”